Bibliographic Details
| Title: |
Optimizing Betalactam Clinical Response by Using a Continuous Infusion: A Comprehensive Review. |
| Authors: |
Diamantis, Sylvain, Chakvetadze, Catherine, de Pontfarcy, Astrid, Matta, Matta |
| Source: |
Antibiotics (2079-6382); Jun2023, Vol. 12 Issue 6, p1052, 12p |
| Subject Terms: |
DRUG resistance in microorganisms, CRITICALLY ill, SURVIVAL rate, MEDLINE |
| Abstract: |
Introduction: Antimicrobial resistance is a major healthcare issue responsible for a large number of deaths. Many reviews identified that PKPD data are in favor of the use of continuous infusion, and we wanted to review clinical data results in order to optimize our clinical practice. Methodology: We reviewed Medline for existing literature comparing continuous or extended infusion to intermittent infusion of betalactams. Results: In clinical studies, continuous infusion is as good as intermittent infusion. In the subset group of critically ill patients or those with an infection due to an organism with high MIC, a continuous infusion was associated with better clinical response. Conclusions: Clinical data appear to confirm those of PK/PD to use a continuous infusion in severely ill patients or those infected by an organism with an elevated MIC, as it is associated with higher survival rates. In other cases, it may allow for a decrease in antibiotic daily dosage, thereby contributing to a decrease in overall costs. [ABSTRACT FROM AUTHOR] |
|
Copyright of Antibiotics (2079-6382) is the property of MDPI and its content may not be copied or emailed to multiple sites or posted to a listserv without the copyright holder's express written permission. However, users may print, download, or email articles for individual use. This abstract may be abridged. No warranty is given about the accuracy of the copy. Users should refer to the original published version of the material for the full abstract. (Copyright applies to all Abstracts.) |
| Database: |
Complementary Index |
